Product NDC: | 60505-2807 |
Proprietary Name: | Carbamazepine |
Non Proprietary Name: | Carbamazepine |
Active Ingredient(s): | 300 mg/1 & nbsp; Carbamazepine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-2807 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078986 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120323 |
Package NDC: | 60505-2807-0 |
Package Description: | 10 BLISTER PACK in 1 CARTON (60505-2807-0) > 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK |
NDC Code | 60505-2807-0 |
Proprietary Name | Carbamazepine |
Package Description | 10 BLISTER PACK in 1 CARTON (60505-2807-0) > 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK |
Product NDC | 60505-2807 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Carbamazepine |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120323 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | CARBAMAZEPINE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |